Conjugated Psilocin™ is a patented, oral, and stable analog of psilocin, which is the active metabolite of psilocybin. This compound has been engineered for enhanced stability and bioavailability, making it more suitable for clinical use compared to traditional psilocin formulations.

• ·Oral administration
• ·Increased stability
• ·Improved bioavailability
• ·Potential therapeutic efficacy in treating neurological and psychiatric disorders